Inventor
ROSINI GOFFREDO
IT16 patents
⚠️ This page may combine multiple inventors who share the name “ROSINI GOFFREDO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALFA WASSERMANN SPA
10 patentsUS7045620B2May 16, 2006
Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations
ALFA WASSERMANN SPA139 citations98
US7906542B2Mar 15, 2011
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ALFA WASSERMANN SPA40 citations96
US7612199B2Nov 3, 2009
Polymorphic forms α, β, and γ of rifaximin
ALFA WASSERMANN SPA45 citations93
US8853231B2Oct 7, 2014
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ALFA WASSERMANN SPA15 citations92
US8835452B2Sep 16, 2014
Polymorphic forms α, β and γ of rifaximin
ALFA WASSERMANN SPA15 citations92
US7902206B2Mar 8, 2011
Polymorphic forms α, β and γ of rifaximin
ALFA WASSERMANN SPA28 citations92
US7923553B2Apr 12, 2011
Processes for the production of polymorphic forms of rifaximin
ALFA WASSERMANN SPA18 citations84
US5663389ASep 2, 1997
3,4-Dihydro-2-iodomethyl-2,5,7,8-tetramethyl-2H-1-benzopyrans
ALFA WASSERMANN SPA3 citations60
US5608084AMar 4, 1997
Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
ALFA WASSERMANN SPA3 citations56
US8765778B2Jul 1, 2014
Rifamycin derivatives
ALFA WASSERMANN SPA1 citations49
VISCOMI GIUSEPPE CLAUDIO
4 patentsUS8173801B2May 8, 2012
Processes for the production of polymorphic forms of rifaximin
VISCOMI GIUSEPPE CLAUDIO14 citations92
US8158644B2Apr 17, 2012
Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
VISCOMI GIUSEPPE CLAUDIO26 citations92
US8158781B2Apr 17, 2012
Polymorphic forms α, β and γ of rifaximin
VISCOMI GIUSEPPE CLAUDIO27 citations92
US8318763B2Nov 27, 2012
Rifamycin derivatives
VISCOMI GIUSEPPE CLAUDIO5 citations69